Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options$1. .$1
Biopharmaceuticals β’ Pain β’ CNS β’ Narcolepsy β’ Major Depressive Disorder
201 - 500
π° $200M Post-IPO Equity on 2019-12
March 29
201 - 500
πΊπΈ United States β Remote
π΅ $115k - $130k / year
π° $200M Post-IPO Equity on 2019-12
β° Full Time
π Senior
π Compliance
March 22
201 - 500
πͺπͺ Estonia β Remote
π΅ $110k - $150k / year
π° $200M Post-IPO Equity on 2019-12
β° Full Time
π‘ Mid-level
π Senior
π Customer Success + Account Manager